SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-086129
Filing Date
2024-04-03
Accepted
2024-04-03 17:26:02
Documents
15
Period of Report
2024-04-03
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d822694d8k.htm   iXBRL 8-K 24707
2 EX-99.1 d822694dex991.htm EX-99.1 2774
6 GRAPHIC g822694g0404015729548.jpg GRAPHIC 5389
  Complete submission text file 0001193125-24-086129.txt   154826

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA orgo-20240403.xsd EX-101.SCH 2855
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE orgo-20240403_lab.xml EX-101.LAB 17234
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE orgo-20240403_pre.xml EX-101.PRE 10815
19 EXTRACTED XBRL INSTANCE DOCUMENT d822694d8k_htm.xml XML 3535
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Filer) CIK: 0001661181 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37906 | Film No.: 24820230
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)